Χώρα: Αυστραλία
Γλώσσα: Αγγλικά
Πηγή: Department of Health (Therapeutic Goods Administration)
fluorouracil, Quantity: 500 mg
Sandoz Pty Ltd
Injection, solution
Excipient Ingredients: sodium hydroxide; water for injections
Intravenous
5 vials, 1 vial
(S4) Prescription Only Medicine
Alone or in combination, for the palliative treatment of malignant tumours, particularly of the breast, colon, rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervical particularly), ovarian and bladder carcinomas. Fluorouracil should only be used when other proven measures have failed or are considered impractical.
Visual Identification: Clear and colourless solution, free of particles.; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 2 Years; Container Temperature: Store between 8-25 degrees celsius
Licence status A
2006-03-15